Scribd Logo
Hochladen

Willkommen bei Scribd!

  • CREW: Food and Drug Administration: Regarding Communications Between The FDA and Martin Shkreli: 8/15/2011 - FDA Response

    Hochgeladen von

    CREW
    116 Ansichten1 Seite
    On July 28, 2011, as part of a larger effort to ascertain the extent to which Wall Street investors are attempting to influence agency policy and regulation, CREW sent a Freedom of Information Act (FOIA) request to the Food and Drug Administration. CREW’s request seeks records of all communications between FDA and Martin Shkreli, CEO of the hedge fund MSMB Capital Management. Mr. Shkreli already has sought to influence the FDA’s drug approval process based on companies in which he held short positions.

    Originaltitel

    CREW: Food And Drug Administration: Regarding Communications Between the FDA and Martin Shkreli: 8/15/2011 - FDA Response

    Copyright

    © Public Domain

    Verfügbare Formate

    PDF, TXT oder online auf Scribd lesen

    Stufen Sie dieses Dokument als nützlich ein?

    Sind diese Inhalte unangemessen?

    Dieses Dokument melden
    On July 28, 2011, as part of a larger effort to ascertain the extent to which Wall Street investors are attempting to influence agency policy and regulation, CREW sent a Freedom of Information Act (FOIA) request to the Food and Drug Administration. CREW’s request seeks records of all communications between FDA and Martin Shkreli, CEO of the hedge fund MSMB Capital Management. Mr. Shkreli already has sought to influence the FDA’s drug approval process based on companies in which he held short positions.

    Copyright:

    Public Domain
    Als PDF, TXT herunterladen oder online auf Scribd lesen
    Markieren Sie unangemessene Inhalte
    116 Ansichten1 Seite

    CREW: Food and Drug Administration: Regarding Communications Between The FDA and Martin Shkreli: 8/15/2011 - FDA Response

    Hochgeladen von

    CREW
    On July 28, 2011, as part of a larger effort to ascertain the extent to which Wall Street investors are attempting to influence agency policy and regulation, CREW sent a Freedom of Information Act (FOIA) request to the Food and Drug Administration. CREW’s request seeks records of all communications between FDA and Martin Shkreli, CEO of the hedge fund MSMB Capital Management. Mr. Shkreli already has sought to influence the FDA’s drug approval process based on companies in which he held short positions.

    Copyright:

    Public Domain
    Als PDF, TXT herunterladen oder online auf Scribd lesen
    Markieren Sie unangemessene Inhalte
    von 1

    DEPARTMENT OF HEALTH & HUMAN SERVICES

    Public Health Service Food and Drug Administration Rockville MD 20857

    August 9, 2011

    In reply to: 2011-5576 Anne L. Weismann Citizen for Responsibility and Ethics in Washington (CREW) 1400 Eye Street, N.W., Suite 450 Washington, DC 20005

    Dear Ms. Weismann: This is in response to your request for records from the Food and Drug Administration (FDA) pursuant to the Freedom of Information Act. Enclosed are the records you requested: Refrain From Approving Investigational Radioactive Sentinel Lymph Node Detection Agents Without Accompanying Data From Successful Controlled Trials of Such Agents, docket FDA-2011-P-0450-0003, comment. Another office will respond to the other portion of your request. You will receive an invoice from the Freedom of Information Staff. The charges listed below may not reflect the final charges for this request. Please do not send payment until you receive an invoice.

    Reproduction

    0.30

    Certification

    CD-ROM

    Total

    0.30

    If you have any questions, please contact Ms. Michelle Bigesby at 301-827-6857. Sincerely yours,

    Karen Kennard Director, Division of Dockets Management Office of Public Information and Library Services Office of Shared Services Office of Management Enclosure

    Das könnte Ihnen auch gefallen